Cardiac resynchronization therapy-defibrillator

DEVICE2 trials

Sponsors

Abbott Medical Devices, Boston Scientific Corporation

Conditions

First Degree AV BlockHeart Failure

Unknown Phase

RISK Stratification Using a Combination of Cardiac Troponin T and Brain Natriuretic Peptide in Patients Receiving CRT-D

CompletedNCT00453622

Abbott Medical DevicesHeart Failure

Start: 2005-11-30End: 2012-08-31Updated: 2019-02-04

Restoration of Atrioventricular Synchrony Trial

TerminatedNCT01275833

Boston Scientific CorporationFirst Degree AV Block

Start: 2011-07-31End: 2012-01-31Updated: 2017-06-26